OR WAIT null SECS
© 2023 MJH Life Sciences™ and Pharmaceutical Commerce. All rights reserved.
Deal is expected to boost company’s market access capabilities.
Fingerpaint Group, an integrated collective of healthcare companies that provide commercialization solutions that span the entire product life cycle, is strengthening its market access offering with the acquisition of The MYND Group, a full-service strategic market access marketing company that works in the pharma and biologics spaces.
The company joins Fingerpaint Group's specialty services offerings that include medical and scientific communications, market access, and naming and branding capabilities.
"The MYND Group brings extensive market access strategy, research, and launch experience across multiple categories, including in the growing vaccine category," notes Bill McEllen, Fingerpaint Group’s global president. "This is our second market access acquisition in the last 3 years and is part of our continued commitment to evolving our market access capabilities to match the expectations and needs of the industry."